Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy

John Gorcsan1, Olusegun Oyenuga, Phillip J Habib

  • 1University of Pittsburgh, Scaife 564, 200 Lothrop St, Pittsburgh, PA 15213-2582, USA. gorcsanj@upmc.edu

Circulation
|October 27, 2010
PubMed

Insights

Echocardiographic dyssynchrony predicts long-term survival in heart failure patients receiving cardiac resynchronization therapy (CRT). Lack of dyssynchrony, especially with narrower QRS duration, indicates a poorer prognosis after CRT.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Management

Background:

  • Predicting response to cardiac resynchronization therapy (CRT) using echocardiographic dyssynchrony remains challenging.
  • Heart failure patients often have complex electrical and mechanical dyssynchronies impacting treatment efficacy.

Purpose of the Study:

  • To test the hypothesis that baseline echocardiographic dyssynchrony predicts long-term survival in patients undergoing CRT.
  • To identify specific echocardiographic dyssynchrony indexes associated with improved outcomes after CRT.

Main Methods:

  • Prospective, longitudinal study of 229 heart failure patients (NYHA class III-IV, LVEF ≤35%, QRS duration ≥120 ms) receiving CRT.
  • Assessed baseline dyssynchrony using tissue Doppler, 12-site standard deviation (Yu Index), speckle tracking radial strain, and pulsed Doppler interventricular mechanical delay.
  • Primary outcome was freedom from death, heart transplantation, or left ventricular assist device implantation over 4 years.

Main Results:

  • Of 210 patients with available data, 62 experienced adverse events (47 deaths, 9 transplants, 6 LVADs) over 4 years.
  • Event-free survival was significantly associated with Yu Index, speckle tracking radial strain, and interventricular mechanical delay.
  • Yu Index and radial strain dyssynchrony remained independent predictors of outcome after adjusting for ischemic origin and QRS duration.

Conclusions:

  • Absence of echocardiographic dyssynchrony was linked to less favorable event-free survival post-CRT.
  • Patients with narrower QRS duration (<150 ms) lacking dyssynchrony exhibited the poorest long-term outcomes.
  • These findings reinforce the critical role of echocardiographic dyssynchrony in predicting CRT response and guiding therapy.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.